GS-9620

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2017
02420132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND & AIMS Vesatolimod (GS-9620) is an oral agonist of toll-like receptor 7, an activator of innate and adaptive immune… (More)
Is this relevant?
2017
2017
GS-9620 is a potent and selective oral Toll-like receptor 7 (TLR7) agonist that directly activates plasmacytoid dendritic cells… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2017
2017
Antiretroviral therapy can suppress HIV replication to undetectable levels but does not eliminate latent HIV, thus necessitating… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
GS-9620 is an orally administered agonist of Toll-like receptor (TLR)7 currently being evaluated in clinical studies for the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
BACKGROUND & AIMS GS-9620 is an oral agonist of toll-like receptor 7, a pattern-recognition receptor whose activation results in… (More)
  • figure 2
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
BACKGROUND & AIMS New therapies for chronic hepatitis B (CHB) are urgently needed since current treatments rarely lead to cure… (More)
  • table 1
  • table 2
Is this relevant?
2015
2015
BACKGROUND GS-9620 is a potent oral agonist of toll-like receptor 7, a key modulator of the innate immune response. In healthy… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2014
2014
GS-9620 [8-(3-(pyrrolidin-1-ylmethyl)benzyl)-4-amino-2-butoxy-7,8-dihydropteridin-6(5H)-one] is a potent, orally bioavailable… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND & AIMS Direct-acting antiviral agents suppress hepatitis B virus (HBV) load, but they require life-long use… (More)
Is this relevant?
2013
2013
BACKGROUND GS-9620 is a novel oral agonist of Toll-like receptor 7 (TLR7) in development for the treatment of chronic viral… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?